Cytomegalovirus attenuation method and vaccine

Details Cytomegalovirus attenuation method and vaccine Cytomegalovirus attenuation method and vaccine

1974-12-17

1977-11-15

Rosen, Sam

Drug, bio-affecting and body treating compositions

Lymphokine

195 13, A61K 3912, C12K 700

Patent

active

040585980

ABSTRACT:
An attenuated strain of cytomegalovirus is prepared by serial passage in human tissue culture cells. The stain of virus so attenuated is incorporated into vaccines and used for developing immunity in humans against infections with cytomegalovirus.

REFERENCES:
patent: 3959466 (1976-05-01), Plotkin
Probstmeyer et al., Chem. Abst., vol. 66 (1967) p. 92561x.
McAllister et al., Chem. Abst., vol. 66 (1967) p. 113,099v.
Elek et al., Lancet, Jan. 5, 1974, pp. 1-5.

Affiliated with

Also associated with

Rating

Cytomegalovirus attenuation method and vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytomegalovirus attenuation method and vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytomegalovirus attenuation method and vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1720234